Hiroaki Onda Selected Research

Hiroaki Onda Research Topics

Disease

10	Neoplasms (Cancer) 09/2021 - 03/2002
10	Tuberous Sclerosis (Bourneville's Disease) 05/2007 - 03/2002
4	Hamartoma 05/2007 - 03/2002
3	Seizures (Absence Seizure) 05/2007 - 06/2002
2	Fibrosis (Cirrhosis) 01/2024 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2017
2	Adenocarcinoma 01/2017 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 08/2008 - 01/2005
2	Epilepsy (Aura) 08/2006 - 12/2002
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2005 - 03/2002
2	Autistic Disorder (Autism) 12/2002 - 06/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024
1	Drug-Related Side Effects and Adverse Reactions 11/2022
1	Inflammation (Inflammations) 11/2022
1	Obesity 09/2021
1	Hypoxia (Hypoxemia) 03/2011
1	Vasculitis (Vasculitides) 08/2008
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2005
1	Cystadenoma 10/2003
1	Carcinogenesis 08/2003
1	Angiomyolipoma 09/2002
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2002
1	Intellectual Disability (Idiocy) 06/2002
1	Astrocytoma (Pilocytic Astrocytoma) 06/2002
1	Focal Cortical Dysplasia 06/2002
1	Hemangioma (Angioma) 03/2002

Drug/Important Bio-Agent (IBA)

8	trans-sodium crocetinate (crocetin)IBA 05/2007 - 03/2002
3	Tuberous Sclerosis Complex 2 ProteinIBA 12/2005 - 09/2002
3	Phosphotransferases (Kinase)IBA 08/2003 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2003
2	Tuberous Sclerosis Complex 1 ProteinIBA 12/2005 - 08/2003
2	Sirolimus (Rapamycin)FDA Link 03/2005 - 10/2003
1	IntegrinsIBA 01/2024
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	Calcium-Binding ProteinsIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	TeaIBA 09/2021
1	PolyphenolsIBA 09/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 09/2021
1	Phosphodiesterase 3 InhibitorsIBA 01/2017
1	Cyclic GMPIBA 01/2017
1	Laminin ReceptorsIBA 01/2017
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	EnzymesIBA 03/2011
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 03/2011
1	TOR Serine-Threonine KinasesIBA 03/2011
1	Protein Isoforms (Isoforms)IBA 03/2011
1	Pyruvate KinaseIBA 03/2011
1	IsoenzymesIBA 03/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2008
1	Anti-Idiotypic AntibodiesIBA 08/2008
1	Complementary DNA (cDNA)IBA 08/2008
1	Genetic Markers (Genetic Marker)IBA 08/2008
1	Chemokine ReceptorsIBA 08/2006
1	Tacrolimus Binding Proteins (FKBP)IBA 08/2006
1	Messenger RNA (mRNA)IBA 08/2006
1	protein-tyrosine sulfotransferase (tyrosylprotein sulfotransferase)IBA 08/2006
1	NF-kappa B (NF-kB)IBA 08/2006
1	C-Type Lectins (C-Type Lectin)IBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 03/2005
1	Inosine Triphosphate (ITP)IBA 01/2005
1	Platelet-Derived Growth Factor alpha ReceptorIBA 10/2003
1	Epidermal Growth Factor (EGF)IBA 10/2003
1	Insulin (Novolin)FDA Link 10/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2003
1	MitogensIBA 08/2003
1	AntibodiesIBA 08/2003
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2003
1	Tyrosine (L-Tyrosine)FDA Link 09/2002
1	Tyrosine Kinase InhibitorsIBA 09/2002
1	Imatinib Mesylate (Gleevec)FDA Link 09/2002
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2002
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2002
1	bcr-abl Fusion ProteinsIBA 09/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2017 - 01/2017
2	Therapeutics 03/2005 - 09/2002